A significant breakthrough in cancer study is arising with the use of mini-antibodies to re-engage mutated p53. This vital malignant inhibitor protein is frequently disabled in many types of tumors, resulting https://xyzbookmarks.com/story21761684/vhh-fragments-reactivate-p53-a-promising-approach-for-malignant-therapy